1. Blass EM, Camp CA. The ontogeny of face recognition: eye contact and sweet taste induce face preference in 9- and 12-week-old human infants.
2. Brink PJ. Addiction to sugar.
3. Smith BA, Fillion TJ, Blass EM. Orally mediated sources of calming in 1-to 3-day-old infants.
4. Blass EM, Ciaramitaro V. Oral determinants of state, affect, and action in new-born humans.
5. Morley JE, Levine AS, Yamada T, et al. Effect of exorphins on gastrointestinal function, hormonal release, and appetite.
6. Fukudome S, Yoshikawa M. Gluten exorphin C: A novel opioid peptide derived from wheat gluten.
7. Dohan FC. Genetic hypothesis of idiopathic schizophrenia: its exorphin connection.
1. Drewnowski A, Krahn DD, Demitrack MA, Nairn K, and Gosnell BA. Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement.
2. Pennington JAT.
3. Koehler PE, Eitenmiller RR. High pressure liquid chromatographic analysis of tyramine, phenylethylamine and tryptamine in sausage, cheese, and chocolate.
4. Hurst WJ, Martin RA, Zoumas, BL. Biogenic amines in chocolate: a review.
5. di Tomaso E, Beltramo M, Piomelli D. Brain cannabinoids in chocolate.
6. Tuomisto T, Hetherington MM, Morris MF, Tuomisto MT, Turjanmaa V, Lappalainen R. Psychological and physiological characteristics of sweet food "addiction."
7. Michener W, Rozin P. Pharmacological versus sensory factors in the satiation of chocolate craving.
8. Macdiarmid JI, Hetherington MM. Mood modulation by food: an exploration of affect and cravings in "chocolate addicts."
9. Drewnowski A. Taste preferences and food intake.
10. Michell GF, Mebane AH, Billings CK. Effect of bupropion on chocolate craving.
11. Shapira NA, Goldsmith TD, McElroy SL. Treatment of binge-eating disorder with topiramate: a clinical case series.
1. Hazum E, Sabatka JJ, Chang KJ, Brent DA, Findlay JWA, Cuatrecasas P. Morphine in cow and human milk: Could dietary morphine constitute a ligand for specific morphine (μ) receptors?
2. Benyhe S. Morphine: new aspects in the study of an ancient compound.
3. Meisel H, FitzGerald RJ. Opioid peptides encrypted in intact milk protein sequences.
4. Panksepp J, Normansell L, Siviy S, Rossi J, Zolovick AJ. Casomorphins reduce separation distress in chicks.
5. Shah NP. Effects of milk-derived bioactives: an overview.
6. Meisel H. Chemical characterization of opioid activity of an exorphin isolated from in vivo digests of casein.
7. Teschemacher H, Umbach M, Hamel U, et al. No evidence for the presence of β-casomorphin in human plasma after ingestion of cows' milk or milk products.
8. Umbach M, Teschemacher H, Praetorius K, Hirschhäuser R, Bostedt H. Demonstration of a β-casomorphin immunoreactive material in the plasma of newborn calves after milk intake.
9. Chabance B, Marteau P, Rambaud JC, Migiiore-Samour D, Boynard M, Perrotin P, Guillet R, Jollés P, Fiat AM. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt.
10. Clyne PS, Kulczycki A. Human breast milk contains bovine IgG. Relationship to infant colic?
11. Lindström LH, Nyberg F, Terenius L, et al. CSF and plasma β-casomorphin-like opioid peptides in postpartum psychosis.
12. Nyberg F, Lindström LH, Terenius L. Reduced beta-casein levels in milk samples from patients with postpartum psychosis.